Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.63 |
| ▸ | GSK3B | P49841 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 3/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.48 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 7/20 | 0.45 |
| ▸ | RAB9A | P51151 | 7/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.45 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ACP1 | P24666 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23256895 | 0.84 | DYRK1A (0.68) | DYRK1AGSK3BLCKABL1NPC1 | |
| SCHEMBL26034949 | 0.80 | DYRK1A (0.61) | DYRK1AGSK3BLCKNPC1RAB9A | |
| SCHEMBL21568130 | 0.78 | DYRK1A (0.65) | DYRK1AGSK3BLCKPIK3CGABL1 | |
| SCHEMBL21568244 | 0.78 | DYRK1A (0.58) | DYRK1AGSK3BABL1NPC1RAB9A | |
| SCHEMBL21568692 | 0.78 | DYRK1A (1.00) | DYRK1AGSK3BPIK3CGNPC1RAB9A | |
| SCHEMBL23256896 | 0.78 | DYRK1A (0.58) | DYRK1AGSK3BLCKPIK3CGABL1 | |
| SCHEMBL23256870 | 0.78 | DYRK1A (0.70) | DYRK1AGSK3BLCKNPC1RAB9A | |
| SCHEMBL6068126 | 0.78 | DYRK1A (0.71) | DYRK1AGSK3BPIK3CGABL1NPC1 | |
| SCHEMBL21568324 | 0.77 | DYRK1A (0.58) | DYRK1ALCKNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21568059 | 0.77 | DYRK1A (0.60) | DYRK1AGSK3BPIK3CGNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731985-B2 | Compositions and methods for treating cancer | HB THERAPEUTICS INC. (US) | 2023-08-22 | — | — | US | disclosed |
| US-20210115064-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | HB THERAPEUTICS INC. (US) | 2021-04-22 | — | — | US | disclosed |
| WO-2019217509-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | HB THERAPEUTICS INC. (US) | 2019-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731985-B2 | Compositions and methods for treating cancer | VHL, TP53, NUDT1 | DYRK1A 4664/4885GSK3B 4096/4885LCK 703/4885 |
| US-20210115064-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | VHL, TP53, NUDT1 | DYRK1A 4618/4885GSK3B 4200/4885LCK 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.